Author | Daniel Morgensztern, MD | OncLive

Author | Daniel Morgensztern, MD


Dr. Morgensztern on Impact of Immunotherapy on NSCLC Field

May 11, 2017


Daniel Morgensztern, MD, associate professor, Department of Medicine, Oncology Division, Medical Oncology, Washington University School of Medicine in St. Louis, discusses the monumental impact that immunotherapy has had on the field of non–small cell lung cancer (NSCLC).